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Castellanos, Amber. M.S., Department of Neuroscience, Cell Biology, and Physiology, 
Wright State University, 2020. The role of IGF-1 in geriatric skin. 
Keratinocytes are cells that largely occupy the epidermis layer of our skin and function to 
protect against DNA damage induced by ultraviolet radiation. Keratinocytes rely on the 
activation of the IGF-1 receptor in order to carry out an appropriate response to UV-B 
radiation. Keratinocytes themselves do not express the IGF-1 ligand; IGF-1 is produced by 
fibroblasts found in the dermis layer of the skin. With age, fibroblasts become senescent and 
this interferes with their ability to produce IGF-1 for the epidermal IGF-1R. This occurrence 
may aid in understanding why geriatric individuals are at greatest risk for developing non-
melanoma skin cancers, suggesting that age-dependent changes within our skin’s 
microenvironment are an important key factor. In view of these ideas, three aims were 
designed for this thesis to further investigate the role of IGF-1 in geriatric skin.  Studies have 
shown that geriatric individuals have lower levels of IGF-1 than younger people. However, 
there are no current studies that have examined IGF-1 expression among intermediate ages. 
The first aim investigates more specifically when IGF-1 begins to decrease with age. The 
second aim seeks to further confirm the improvement of IGF-1 seen in geriatric skin treated 
with FLR and determine if skin rejuvenation methods have a lasting impact on IGF-1 
expression in geriatric individuals. Lastly, the third aim consists of experiments using an 
IGF-1R inhibitor to treat human skin ex vivo to examine how the deficient IGF-1 signaling 
impacts the utilization of the potentially mutagenic translesion synthesis pathway of DNA 
replication following UVB exposure. These studies further define how the age-dependent 
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I:  INTRODUCTION 
 
SKIN ANATOMY 
 The skin is the largest organ in the body, which functions as a primary barrier 
against pathogens and ultraviolet radiation. It also assists in regulating body temperature by 
controlling the amount of water released into the environment. Ultimately, the skin is 
organized into three layers; the epidermis, dermis and the hypodermis, and each of these 
layers differ significantly in terms of their structure and function (Yousef & Sharma, 2018). 
 The epidermis is the outermost layer of the skin and therefore serves as the body’s 
first point of contact with the environment. In the epidermis, keratinocytes are formed from a 
mitotically active stem cell population in the stratum basale. These cells undergo 
differentiation and migrate towards the most superficial layer of the epidermis, known as the 
stratum corneum.  Keratinocytes are the most abundant cell type found in the epidermis 
serving many functions such as producing keratin and establishing a water barrier.  In 
addition to forming an effective physical barrier, keratinocytes also accumulate melanin as 
they differentiate. Melanin functions to block UVR into the skin and can be found in 
abundance in epidermal keratinocytes although melanin is formed by melanocytes occupying 
the stratum basale (D’Orazio et al., 2013).    
 The dermis underlies the epidermis and houses different cutaneous structures like hair 
follicles, neurovasculature and various glands. These structures provide support and 
protection to the skin, as well as aid in thermoregulation and sensation(Brown & 





and elastic fibers. These elements help maintain the integrity of the skin and provide 
elasticity. Similarly to the epidermis, the dermis also has many cell types. Dermal fibroblasts 
are the most abundant and are responsible for many extracellular matrix components that 
form the connective tissue of the skin, ultimately playing an important role in wound healing. 
Other important cells function in immune and inflammatory responses.  
 The hypodermis is the deepest layer of the skin. Composed of loose connective and 
adipose tissue, this layer serves to store fat and provide insulation. This layer also contains 
fibroblasts and structures that aid in deep touch sensation.  
ULTRAVIOLET RADIATION 
Our skin is continuously exposed to ultraviolet radiation (UVR) from the sun and other 
artificial sources such as tanning beds. This makes our skin highly susceptible to DNA 
damage leading to skin cancers, as well as UVR associated skin aging, a concept known as 
photo-aging (Panich et al., 2016).  
UVR produced from the sun can be categorized into three types according to their 
wavelength: UV-A between 315-400 nm, UV-B between 280-315 nm and UV-C between 
100-280 nm. Longer wavelengths of lower energy penetrate into deeper layers of the skin 
while high energy; shorter wavelengths are dispersed and absorbed with a higher degree. As 
illustrated in Figure 1, UV-A can penetrate deep into the dermis of the skin, whereas UV-B 
only reaches the epidermal layers (Gupta et al., 2013). While both these types of radiation 
penetrate the skin, the DNA in epidermal cells directly absorb UV-B and induce more 
damage, even at much lower doses compared to UV-A (Budden & Bowden, 2013).  UV-C is 






A schematic illustrating ultraviolet radiation wavelengths and their penetration into skin. UV-
A has wavelengths between 315-400 nm and can penetrate into the dermis of the skin. UV-B 
has wavelengths between 280-315 nm and can penetrate epidermal layers of skin. UV-C has 






UV-A AND UV-B PHOTOCARCINOGENESIS 
90-95% of UVR reaching the earth’s surface is UV-A, yet it is far less carcinogenic in 
comparison to UV-B. This is because UV-B has a direct mutagenic impact on DNA while 
UV-A indirectly affects DNA by generating reactive oxygen species (ROS).  
UV-A is absorbed predominantly by non-DNA chromophores that become activated and 
generate ROS. This can happen in two ways. In a type I reaction an endogenous 
photosensitizer becomes activated when it absorbs UV-A. This excited photosensitizer then 
directly reacts with DNA. In a type II reaction, upon excitation by UV-A absorption the 
photosensitizer reacts with oxygen, generating ROS, which in turn interacts with DNA. 
These interactions with DNA can cause single stranded DNA breaks as well as DNA-to-
protein crosslinks (De Gruijl, 2000; Reichrath, 2006).  
In the direct interaction that occurs between DNA and UV-B pyrimidine bases absorb 
radiation and this forms cyclobutane pyrimidine dimers (CPD) as well as 6-4 photoproducts 
(6-4 PP). The formation of these photoproducts largely occurs at sites that have thymine 
residues, such as TC or TT. These photoproducts generate bulky lesions that alter the DNA 
helix in a manner that creates adducts that cease transcription and DNA replication (Budden 























Types of UVR induced DNA damage. UV-A is absorbed chromophores that become 
activated and generate ROS. UV-B radiation forms cyclobutane pyrimidine dimers (CPD) as 














DNA DAMAGE REPAIR MECHANISMS   
DNA repair mechanisms exist within our cells that allow appropriate responses when 
genomic stability is altered.  Such mechanisms include things like nucleotide excision repair 
(NER), base excision repair (BER), mismatch repair (MMR), DNA double strand break 
(DSB) repair and post replication repair (PPR) (Kim & He, 2014).  
NER is important for repairing UV-B induced CPDs and 6-4 PPs in two manners. Global 
genome repair (GGR) functions to remove lesions that may contribute to replication 
mutations and transcription-coupled repair (TCR) functions to prevent apoptosis prompted by 
DNA damage through recovering transcriptional activity (Budden & Bowden, 2013). 
 NER damage recognition by global genome repair (GGR) eliminates lesions throughout 
the entire genome regardless of whether transcription has occurred or not.  In this pathway 
DNA-helix lesions such as 6-4 PPs are recognized by DNA damage binding proteins such as 
XPC or XPE. These DNA-binding proteins then bind the lesions and signal for repair 
(Atanassov et al., 2004). In transcription-coupled repair (TCR), damage recognition removes 
lesions from the genome of transcribed regions only. In TCR, RNA polymerase II becomes 
stalled at the lesion and signals for repair via other proteins like CSA or CSB. The 
transcription-coupled repair pathway provides more efficient repair for CPDs compared to 
global genome repair (Hanawalt, 2002). 
Once each pathway has utilized its own unique methods in recognizing the DNA damage, 
they then share a repair pathway moving forward. The first step in this shared pathway is 





bind to the site of the damage and RPA to bind the undamaged strand. Following the binding 
of these proteins endonucleases cleave and excise the damaged strand and DNA polymerase 
in combination with PCNA synthesize new DNA that is fixed to the old DNA by DNA 
ligase. 
DNA damage linked to indirect UV-A absorption can be removed in two manners: the 
first by NER as described above, and the second by BER involving glycosylase enzymes to 
initiate removal of lesions (Reichrath, 2006).  
WHY IS IGF-1 IMPORTANT? 
Continuous exposure to UVR and additional factors that may contribute to injury 
necessitates the need for a mechanism of renewal and self-repair in our skin. This is achieved 
by stem cells that reside in the stratum basale layer of the epidermis that give rise to 
keratinocytes capable of differentiation and proliferation. It is evident that this mechanism of 
self-renewal is beneficial to epidermal keratinocytes that function to block UVR induced 
damage to our skin, but every system has its drawbacks. Constant proliferation of epidermal 
keratinocytes increases the possibility of malignant genetic mutations (Gandarillas, 2000).  
Insulin-like growth factor 1 (IGF-1) is a key player in a majority of signals for 
cellular proliferation, differentiation and survival. The IGF-1 ligand is made by dermal 
fibroblasts and acts to stimulate epidermal repair and renewal when bound to the IGF-1 
receptor (IGF-1R) that is expressed in keratinocytes (Kemp et al., 2017). The activation of 
IGF-1R by IGF-1 initiates phosphorylation in a variety of downstream signaling pathways, 





fibroblasts from UV-B induced programmed cell death via PI3PK/AKT pathway activation 
and aids in cell survival through the MAPK pathway (Héron-Milhavet et al., 2001).  
In vivo, human keratinocytes have been shown to be highly dependent on IGF-1/IGF-
1R activity as well. Studies show that without IGF-1 keratinocytes negatively interfere with 
the rate of UV-B induced DNA damage repair yet enhances this repair in the presence of 
IGF-1R activation. In addition to these findings, IGF-1/IGF-1R activity has been found to 
enhance the levels of genes associated with NER following UV-B radiation (Loesch et al., 
2016). Through these findings, it is evident that IGF-1 signaling is overall exceptionally 
important to the skin by initiating the many different repair mechanisms when keratinocytes 
are exposed to mutagenic UVR. 
SKIN CANCER RISK FACTORS AND AGING 
Exposure to ultraviolet radiation has been historically recognized as one of the most 
imperative risk factors contributing to melanomas of the skin. Former studies have correlated 
increasing sun exposure during adult life to skin cancer risk (Mark Elwood & Jopson, 1997), 
while more recent publications have established a relationship between skin cancer risk and 
sun exposure during childhood (Amaro-Ortiz et al., 2014; Green et al., 2011). It is believed 
that the anatomical differences in our skin that are present in the earlier years of life allow 
UVR to penetrate more deeply into our skin (Volkmer & Greinert, 2011). The damage 
inflicted in our early life can introduce keratinic mutations that may ultimately lead to skin 





In addition to extrinsic, environmental factors, such as the sun, intrinsic elements 
within our body can also cause mutations. The accrual of DNA damage within our cells is 
largely dependent on intrinsic factors such as the production of ROS and defense 
mechanisms that act to remove ROS. In order to further understand the interplay between 
ROS and skin cancers, we must familiarize ourselves with Denham Harman’s Free Radical 
Theory of Ageing. In this theory, ROS contribute to the process of aging by triggering 
cellular damage (Pomatto & Davies, 2018). If this damage goes unrepaired it can cause 
cellular senescence, or biological aging (J. H. Chen et al., 2007). Cellular senescence 
interferes with the ability of damaged tissues to repair themselves. This phenomenon, in 
combination with age-related decline in DNA repair mechanisms, might explain why skin 
cancers are most often diagnosed in people who are between the ages of 65 and 74 (SEER, 
2019). All in all, these findings all suggest that age is an additional risk factor imperative to 









Figure 3  
A diagram illustrating the relationship between potential skin cancer risk factors. Increased 
childhood and adulthood sun exposure can increase the risk of developing skin cancers. With 
age, DNA repair mechanisms decline which can result in skin cancers. Also with age, the 
production of ROS is increased, which can result into skin cancers.  
IGF-1, AGING AND NMSCs 
When briefly exposed to UV-B radiation, keratinocytes halt their proliferation to 





UV-B on the other hand, can cause keratinocytes to undergo apoptosis or become senescent. 
These responses to prolonged UVR are normal protective mechanisms that keratinocytes 
possess in order to prevent replication of mutagenic DNA. Failure of either mechanism to 
occur can cause keratinocytes to replicate these mutations when DNA is repaired incorrectly 
and these cells continue to proliferate (Lewis, Travers, & Spandau, 2010).  
Aforementioned in the discussion about skin cancer risk factors, UVR is not the sole 
contributor to the development of NMSCs. Age, and age-related changes have also proven to 
be contributing factors. As we age, the fibroblasts in the dermal layer of our skin also age and 
become senescent. This senescence interferes with the fibroblasts’ ability to produce IGF-1 
for the epidermal IGF-1R. The relationship between dermal fibroblasts and epidermal 
keratinocytes is important because through the secretion of IGF-1, dermal fibroblasts are able 
to assist in proper keratinocyte growth (Lewis et al., 2009) and when the health of fibroblasts 
becomes compromised they no longer are able to provide the support needed by 
keratinocytes. This phenomenon has been confirmed both in vitro and in vivo (Ferber et al., 
1993; Lewis et al., 2009).  
The magnitude of importance that IGF-1 has on how keratinocytes respond to UVR 
cannot be underestimated. Prolonged UV exposure to our skin can alter the regulation of 
IGF-1 necessary in order for our skin to maintain homeostatic balance. As illustrated in 
Figure 4, when exposed to UV-B in the absence of IGF-1R activation by IGF-1, 
keratinocytes are more likely to undergo UV-B mediated apoptosis. In the presence of IGF-1, 
IGF-1R becomes activated and keratinocytes are protected by UV-B induced apoptosis and 





when exposed to UV-B radiation, some keratinocytes undergo UV-B mediated apoptosis and 
the surviving keratinocytes do not become senescent. The remaining keratinocytes that do 
not become senescent cannot repair the damage caused by UV-B radiation and can 
potentially introduce mutations to the skin that can cause NMSCs. (Davina A. Lewis & 
Jeffrey B. Travers, 2007; Kuhn et al., 1999; Lewis, Travers, & Spandau, 2010) 
 Recent discoveries in the field of skin cancer research have allowed for further 
understanding in the relationship seen with age and the development of skin cancers. In 2010, 
studies found that geriatric skin has more senescent fibroblasts, and in turn, reduced levels of 
IGF-1, than the skin of younger people (Lewis, Travers, Somani, et al., 2010). If younger 
people have more healthy dermal fibroblasts they are able to produce more IGF-1 and elicit a 
normal response to UV-B.  As demonstrated in Figure 5, geriatric skin, on the other hand, 
contains an accumulation of senescent fibroblasts with a reduced ability to make IGF-1. With 
reduced levels of IGF-1, any DNA damage to keratinocytes in response to UV-B may fail to 
become senescent and may proliferate with this retained damage.  
All together findings are extremely relevant to the field of research dedicated to skin 
cancers because they help target reduced IGF-1 as an additional risk factor in the 




















Figure 4  
NO IGF-1 
 



















In the absence of IGF-1R activation keratinocytes are more likely to undergo apoptosis. 
When activated, keratinocytes become senescent. When IGF-1R is inactive some 
keratinocytes undergo apoptosis and the surviving keratinocytes do not become senescent.  
 
Figure 5  
Punch biopsies from young adults (20-28 years of age) demonstrated fewer senescent 
fibroblasts when compared to geriatric adults (65+ years of age). Using RT-qPCR, IGF-1 
mRNA was measured and the results showed that skin from geriatric individuals had a 
reduced expression of IGF-1 when compared to younger adults. Asterisks indicate a 







PHOTOREJUVENATION TECHNIQUES AND IGF-1 RESTORATION 
 The age-associated accumulation of senescent dermal fibroblasts is responsible for 
the reduction of IGF-1 seen in geriatric skin. Given this information, it is logical to assume 
that IGF-1 restoration therapies might be able to correct the inappropriate UV-B response in 
geriatric skin and ultimately reduce the prevalence of NMSCs in this highly susceptible 
population (Spandau et al., 2012). In fact, many studies have already demonstrated that 
theory in action using photorejuvenation techniques. Dermabrasion and fractionated laser 
resurfacing are two photorejuvenation techniques utilized by dermatologists to reduce the 
appearance of photo-aging. 
 Dermabrasion utilizes an abrasive, motorized rotating tip to remove layers of the skin. 
The mechanical removal of the epidermal, and or upper dermal layers of the skin creates raw 
wounds that heal via epithelialization in about 2 weeks. This epithelialization can reduce the 
appearance of wrinkles, uneven skin tones and acne scars. Fractionated laser resurfacing 
(FLR) utilizes a nonablative laser to that denatures collagen and results in epidermal necrosis. 
Unlike the open wound created by dermabrasion, FLR creates columns of thermal injury to 
only a fraction of the skin by method of coagulation through the epidermis and dermis 
(Friedman & Lippitz, 2009).  
 In 2011, studies found that dermabrasion can protect geriatric skin from the age-
associated IGF-1 decline by reducing senescent fibroblasts. Treatment with dermabrasion 
also corrected the improper response to UV-B by epidermal keratinocytes seen in geriatric 
skin (Lewis et al., 2011). The following year, this same group of individuals reported 





fibroblasts and restoration of appropriate UV-B keratinocyte response in geriatric skin treated 
with FLR (Spandau et al., 2012). Geriatric skin treated with either dermabrasion or FLR 
maintained higher levels of IGF-1 even 3 months after treatment compared to untreated 
controls. The percentage of senescent fibroblasts 3 months after treatment also showed 
promising results with either treatment compared to untreated controls. This data can be seen 














A) Dermabrasion and FLR decreases the amount of senescent fibroblasts found in geriatric 
skin following 3 months of healing. Error bars indicate SEM; asterisks indicate significant 
difference from geriatric control values (p<0.006, student t-test). B) Dermabrasion and FLR 
increases IGF-1 expression in geriatric skin. Error bars indicate SEM; asterisk denotes 
statistical significance of Geriatric Control values from all other cohorts (p<0.02; individual 
paired t-test).  
 Most recently the group acknowledged that their current studies need further 
confirmation of the dermal improvement of IGF-1 after treatment with FLR (R. Chen et al., 
2020). In this thesis, in conjunction with this same group of individuals, I will examine UV-B 
responses in geriatric skin treated with FLR to confirm that the improvement of fibroblast 
IGF-1 levels they reported 3 months after treatment is still present 1 and 2 years post-
treatment.  
HOW AGING AND DEFICIENT IGF-1 CAN IMPACT DNA DAMAGE RESPONSES  
The ultraviolet radiation that penetrates our skin can generate an array of DNA 
abnormalities. The most harmful, and most often occurring abnormalities are UV-B induced 
photoproducts that can stall DNA replication on replication forks. Cyclobutane pyrimidine 
dimers (CPD) and 6-4 photoproducts (6-4 PP) made in response to UV-B radiation are 
especially damaging because normal DNA polymerases are incapable of accommodating the 
changes in the DNA helix which can result in sites of unwound single stranded DNA 
(ssDNA) (Gargi Ghosal and Junjie Chen, 2013). Usually, cells avoid replication arrest by 





bypassing damaged lesions by utilizing DNA damage tolerance pathways (DDT) (Leung et 
al., 2019). 
 Two major DDT pathways exist, one called the translesion synthesis (TLS) pathway 
and the second called template switching (TS) (Chang & Cimprich, 2009). Both of these 
tolerance pathways allow the cell to continue replication over the bulky adduct and can 
contribute to mutations in their own unique manner. The translesion synthesis (TLS) pathway 
utilizes a low-fidelity TLS polymerase, which is not capable of normal, high fidelity 
polymerase proofreading. Due to its inability to proofread, the TLS pathway can accurately 
base pair lesions or contribute to mutagenesis by incorporating the wrong nucleotides (Bi, 
2015). Unlike the possible, error-prone TLS pathway, template switching (TS) proceeds in an 
error-free manner by using the undamaged sister chromatid as a template for repair (Kanao & 
Masutani, 2017).  
 Proliferating cell nuclear antigen (PCNA) is a protein that encircles DNA at its 
replication fork to direct DNA replication, DNA repair and cell cycle regulation (Kelman Z, 
1997). In recent discoveries, PCNA has been indicated in playing an important role in DNA 
damage tolerance as well through its ubiquitination (Hoege et al., 2002). Upon exposure to 
genotoxic factors, PCNA is either mono- or poly- ubiquitinated on its lysine 164 residue. 
PCNA mono-ubiquitination occurs at bulky DNA lesions that halt replication forks and this 
promotes the error-prone TLS DNA damage tolerance pathway (Kyoo-young Lee and 
Kyungjae Myung, 2008), as illustrated in Figure 7 below. The mono-ubiquitinated PCNA 
can be further poly-ubiquitinated and promotes lesion bypass by template switching (TS) 







Schematic of DNA polymerase and PCNA function on UV-B induced DNA damaged 
templates. DNA polymerases move across DNA strands with the help of PCNA, but become 





ubiquitination occurs at bulky DNA lesions that halt replication forks and this promotes the 
error-prone TLS DNA damage tolerance pathway 
  As early as 1994 evidence came to light that PCNA is stimulated in response to 
UVR. This provided early evidence of PCNA’s involvement at the gene level in response to 
cellular UV damage (Zeng et al., 1994). In 2004, further studies demonstrated an enhanced 
PCNA expression in mice skin was dependent on the dose of UV-B exposure (Moore et al., 
2004). This 2004 study brought into light compelling evidence of PCNA serving as a 
preliminary marker for UVR induced DNA damage repair, yet it warranted further research 
of the protein itself for further understanding. In 2019, a colleague, Rebekah Hutcherson 
demonstrated that UV-B radiation induced PCNA mono-ubiquitination in skin ex vivo, and 
that this mono-ubiquitination is more drastic in the skin of geriatric subjects. This data can be 
seen in Figure 8. This phenomenon raises question about what factors contribute to the 
different UV-B damage responses seen among older people. Could it be that deficient IGF-1 
signaling is responsible for the increased PCNA mono-ubiquitination in geriatric skin? In this 
thesis we will examine the possible increased dependence on the error-prone TLS pathway in 







UV-B induces PCNA mono-ubiquitination in skin ex vivo. Mono-ubiquitination is elevated in 
















































II:  MATERIALS AND METHODS 
SKIN HARVEST 
Discarded, de-identified human skin from abdominoplasty surgeries was used in these 
studies. Patient consent for these experiments was not required because non-identified 
leftover surgical human tissue is considered discarded material by our institution, and 
therefore the studies performed were not in any violation. Small, 6 mm punch biopsies were 
obtained from each sample of discarded human abdominoplasty skin and placed in 
microcentrifuge tubes, subsequently frozen in liquid nitrogen, and stored at −80 °C until 
ready for further processing. A total of 75 punch biopsies were obtained (in duplicate) from 
2016 to 2019.  
 
PURIFICATION OF DERMAL RNA FROM SKIN PUNCH BIOPSIES 
The samples were removed from the −80°C freezer and placed on ice. Each sample 
was heat shocked for 6 seconds in 55-60°C deionized water and then submerged in an ice 
bath for 9 seconds. The samples were blotted dry before separating the epidermis from the 
dermis using a  curette. Any visible adipose tissue was removed with a scalpel and discarded. 
The epidermis that was scraped with a curette was placed into a new microcentrifuge tube 
and stored in a −80°C freezer. The newly separated dermis was cut into smaller individual 
pieces using a scalpel before transfer into a BioMasher II Disposable Micro-Tube (Research 
Products International) containing 500 𝜇l of TRIzol reagent (Thermo Fisher Scientific). 





sample was disrupted for 5 minutes. When the samples were processed, 125 𝜇l of 
Chloroform (Sigma-Aldrich) was added to the BioMasher II Disposable Micro-Tube with the 
disrupted tissue. The samples were vortexed briefly and then kept on ice for 10 minutes 
before centrifugation at maximum speed for 10 minutes.  The top layer, roughly 250 𝜇l, was 
transferred into a new microcentrifuge tube containing 250 𝜇l of 70% RNase-free Ethanol. 
The mixture was vortexed and then loaded entirely into an RNeasy Spin Column (obtained 
from a Qiagen RNeasy Mini Kit) and centrifuged at maximum speed for 20 seconds. The 
flow-through was discarded and the column was washed with 700 𝜇l of the provided Buffer 
RW1. The column was centrifuged again for 20 seconds at maximum speed and the new 
flow-through again discarded. The column was then washed with 500 𝜇l of the provided 
Buffer RPE and centrifuged for 2 minutes at 10,000 rpm. The column was then transferred 
into a new RNeasy Spin Column and centrifuged for 1 minute at maximum speed. The spin 
column was then transferred into a new microcentrifuge tube and 50 𝜇l of RNase-free water 
was added inside the column and allowed to incubate for 3-4 minutes before a final 
centrifugation at 10,000 rpm for 1 minute. The RNA quality (verified by a A260/A280 ratio) 
and concentration (in ng/ 𝜇l) was measured using a NanoDrop Lite Spectrophotometer 
(Thermo Fisher Scientific). The samples were stored at −20°C until they were ready to be 
processed for reverse transcription. 
REVERSE TRANSCRIPTION FOR qRT-PCR 
A QuantiTect Reverse Transcription Kit (Qiagen) was used for reverse transcription. 
The volume of homogenized dermal RNA needed to acquire 200 ng of RNA was calculated. 





Biosystems). The first genomic DNA elimination step was performed by adding 2 𝜇l of 7X 
gDNA Wipeout Buffer, bringing the total volume up to 14 𝜇l before the mixture was heated 
at 42°C for 5 minutes. The samples were then placed on ice while preparing a reverse 
transcription cocktail mix containing 4 𝜇l of Quantiscript RT Buffer, 1 𝜇l of RT Primer Mix 
and 1 𝜇l of Quantiscript Reverse Transcriptase Enzyme, per one reaction. Six 𝜇l of the 
cocktail mix was added to each sample, bringing the total volume to 20 𝜇l before a brief 
centrifugation. The samples were then heated for 15 minutes at 42 ° C, and then heated for an 
additional 5 minutes at 95°C. All processed samples were stored in -20 ° C until use for Q-
PCR.  
QUANTITATIVE PCR  
Quantitative real-time PCR assays were performed in a Bio-Rad CFX96 Touch Real-
Time PCR Detection System. The thermal profile involved an initial 3 minute melting step at 
95 °C followed by 45 cycles at 95 °C for 10 seconds and 55 °C for 30 seconds. The 20X 
Taqman® probes for the gene of interest (IGF-1) and housekeeping gene (Human Beta-2-
Microglobulin) were supplied by Applied Biosytems. The TaqMan Fast Universal PCR 
Master Mix (2x) used was also a product of Applied Biosytems. Using a pBJ1-human B2M 
DNA plasmid (Addgene), serial dilutions of B2M were used to create a standard curve to 
quantify the absolute number of copies of IGF-1.  
FRACTIONATED LASER RESURFACING 
In 2012, human volunteers were recruited from patients treated at dermatology clinics 





School of Medicine.  The studies were in accordance with the Declaration of Helsinki 
Principles and any additional information were previously described (Spandau et al., 2012). 
All subjects were informed of any risks and benefits associated with participating in the 
study. All subjects signed a consent statement verifying their voluntary participation. On a 
small, approximately 5 × 5 cm area of forearm skin volunteers underwent two passes of 
fractionated laser resurfacing using 120 mJ of energy per microspot with a Pearl Fractional 
Laser (Cutera). Anesthesia of any kind was not provided prior to the procedure and wound 
care instructions were provided after the treatment. Human volunteers were asked to return 3 
months. Upon their return, areas of FLR and untreated skin (approximately 1 × 1 cm2) were 
irradiated with 350 J/m2 of UV-B. 4 mm punch biopsies of UV-B irradiated and 3 mm punch 
biopsies of unirradiated skin were obtained 3 months, 6 months, 1 year and 2 years after the 
procedure. The punch biopsies used in these studies were those taken from the patients 1 and 
2 years after the procedure. The samples were frozen in liquid nitrogen inside 
microcentrifuge tubes and stored in in -80 ° C until processing dermal RNA for qRT-PCR to 
examine any long-lasting effects. The relative mRNA expression levels of IGF-1 were 
normalized to B2M expression using an adapted comparative CT method (Livak & 
Schmittgen, 2001).  
TREATMENT OF HUMAN SKIN WITH IGF-1R INHIBITOR 
Discarded, de-identified human skin from abdominoplasty surgeries was also used to 
examine the effects of AG538 on human skin with or without UV-B irradiation. Patient 
consent for these experiments was not required because de-identified, leftover surgical 





performed were not in any violation. The abdominoplasty skin was sectioned into smaller 
pieces that were individually placed inside culture dishes. The skin was treated topically with 
20 𝜇M AG538 (Sigma-Aldrich) or DMSO (Thermo Fisher Scientific), a vehicle control, and 
allowed 30 minutes for drug delivery inside a 37°C water bath incubator. After 30 minutes, 
each experimental sample was exposed to varying amounts of UV-B radiation illustrated in 
Table 1. Samples that were given treatment with either DMSO or AG538 that were not 
subjected to UV-B radiation served as controls. 6 mm punch biopsies were then obtained at 
the time points illustrated in Table 1 and frozen in liquid nitrogen for storage in a -80 ° C 
freezer until use for the preparation of epidermal cell lysates.  
PREPARATION OF EPIDERMAL CELL LYSATES FROM TREATED SKIN 
Samples were removed from the -80 ° C freezer and allowed to thaw on ice. The 
specimens were heat shocked in 55-60° C deionized water for 10-15 seconds and then 
submerged in an ice bath for 10 seconds. . The samples were blotted dry before separating 
the epidermis from the dermis using a curette. Any visible adipose tissue was removed with a 
scalpel and discarded. The dermis that was scraped with a curette was placed into a new 
microcentrifuge tube and stored in a −80 ° C freezer. The newly separated epidermis was 
transferred into a microcentrifuge tube (on ice) containing 200 𝜇l of RIPA lysis buffer 
(Teknova). The epidermal lysates were then subjected to sonication twice before they 
incubated on ice for 10-15 minutes. The samples were centrifuged in a cold room at 
maximum speed for 20 minutes. The pellets were discarded and the soluble lysates were 





quantified by Bradford assay (Bio-Rad Laboratories) and stored in a −20°C freezer until 
further use.  
PROTEIN IMMUNOBLOTTING 
Prepared epidermal cell lysates were separated using SDS-PAGE and then transferred 
on to a nitrocellulose membrane. Each membrane was washed with TBST (Tris-buffered 
saline containing 0.1% Tween-20) and blocked in 5% milk in TBST. Each blot was probed in 
primary antibody dilutions of 1:2000 against PCNA (PC10) (Santa Cruz Biotechnology) and 
1:1000 primary antibody dilutions of Ubiquityl-PCNA (Cell Signaling Technology) 
overnight in TBST. The secondary antibodies that were used included Goat anti-Mouse IgG 
(F(ab’)12 and Goat anti-Rabbit IgG (H+L) (Thermo Fisher Scientific). Chemiluminescence 
was visualized using Clarity Western ECL substrate (Bio-Rad Laboratories) or SuperSignal 
West Femto substrate (Thermo Fisher Scientific) on a Molecular Imager Chemi-Doc XRS + 
imaging system. Using Image Lab (Bio-Rad Laboratories), signals in the linear range of 
detection were quantified and normalized.  
STATISTICAL ANALYSES 
 The raw data for each experiment was submitted to Wright State University’s 
Statistical Consulting Center and was analyzed by Senior Statistical Consultant, Mike 
Bottomley. A linear regression was performed to investigate the research question of when 
IGF-1 mRNA expression decreases with age, and if a significant relationship between IGF-1 
mRNA expression, and age, exist. Separate one sample t-tests were conducted for each 





repeated measures ANCOVA (Analysis of Covariance) was conducted to answer the final 
aim question examining any significant differences between skin treated with the IGF-1R 
inhibitor, AG538, AG538 plus UV, DMSO (vehicle control) and DMSO plus UV. All 
analyses and plots were performed via SAS version 9.4 (SAS Institute, Inc., Cary, NC) and 
RStudio version 1.2.1335 (RStudio, Inc., Boston, MA). A level of significance of _=0.05 was 
used to assess statistical significance. Descriptive statistics and plots can be found in the 

















III:  RESULTS 
IN HUMAN SKIN, IGF-1 GRADUALLY DECREASES WITH AGE 
 In 2010, studies demonstrated reduced levels of IGF-1 in geriatric skin (ages 65 and 
up) when compared to young skin (ages 20-28) (Lewis, Travers, Somani, et al., 2010). With 
reference to that study, an experiment was conducted to measure IGF-1 expression in a 
broader range of ages that have never been examined before.  
 Since senescent fibroblasts are responsible for decreases in IGF-1 expression 
observed with increasing age, it was hypothesized that gradual differences in IGF-1 
expression should be detected when examining skin of intermediate ages. Skin samples 
obtained from individuals within the ages of 20- 67 were examined, and because the 
incidence of NMSCs increases dramatically around the age of 65, it was hypothesized that a 
more substantial drop in IGF-1 expression may be detected in individuals of that age group. 
Discarded abdominoplasty skin was obtained from individuals within the ages of 20-
67. The dermal RNA from each sample was purified and reverse transcription was 
subsequently performed. Each sample was analyzed using quantitative PCR and serial 
dilutions of B2M were used to create a standard curve to quantify the absolute number of 






Standard curve created to quantify the absolute number of copies of IGF-1 using serial 
dilutions of B2M.  
 
In order to examine the relationship between age and IGF-1 expression, a linear 
regression was performed on the data collected using RT-qPCR. As seen in Figure 10 below, 
a gradual decrease in IGF-1 mRNA expression was observed with increasing age. With a p-
value of 0.0464, there is strong evidence suggesting that for every one year of increase in 
age, IGF-1 mRNA expression, on average, decreases by 0.034 (indicated by the estimated 
coefficient of -0.034).  
 
y = -3.0061x + 34.85 

























A linear regression illustrating the relationship between age and IGF-1 mRNA expression. 
The dependent variable is copies of IGF-1 mRNA per 1000 copies of B2M mRNA, and the 
independent variable is age. The p-value is 0.0464, indicating a statistically significant 
relationship between IGF-1 mRNA and age.  
FLR TREATMENT HAS A LASTING IMPACT IN GERIATRIC INDIVIDUALS 
 In studies from 2012, geriatric skin treated with FLR demonstrated higher levels of 





need for further confirmation of the dermal improvement of IGF-1 after treatment with FLR 
constituted the experiment created for the second aim of this thesis. Skin biopsies obtained 
from consented geriatric individuals aged 65 and up were used to confirm that the 
improvement of fibroblast IGF-1 levels that were previously reported 3 months after 
treatment, are still present 1 and 2 years post-treatment.  
Geriatric volunteers underwent two treatments of FLR with a Pearl Fractional Laser 
(Cutera) on a small section of their forearm and asked to return in three months. Permanent 
marker was used to outline the treated areas and pictures were obtained for future reference. 
Upon their return, each individual had a localized area of 1x1 cm of FLR-treated skin, or 
untreated skin irradiated with 350 J/m2 of UV-B.  From each individual, biopsies of FLR-
treated skin and untreated normal skin (controls) were obtained at 3 months, 6 months, 1 year 
and 2 years after treatment. The punch biopsies used in this experiment were those taken 
from the patients 1 and 2 years after the procedure. The dermal RNA from each sample was 
purified for qRT-PCR to examine any long-lasting effects 1, and 2 years post-treatment. The 
relative mRNA expression levels of IGF-1 were normalized to B2M expression using an 
adapted comparative CT method (Livak & Schmittgen, 2001). Tables 1 and 2 below illustrate 








1 year post-treatment 
Subject 
Subject 4 Subject 6 Subject 10 Subject 13 
ΔCt Value (FLR) 9.16 7.10 8.61 7.91 
ΔCt Value (Control) 7.25 5.80 7.82 6.04 
ΔΔCt -1.91 -1.30 -0.79 -1.87 
2^-ΔΔCt (Expression Fold Change) 3.76 2.46 1.72 3.65 
Table 1 Data from geriatric patients 1 year post-treatment with FLR 
2 years post-treatment 
Subject 
GA52 GA55 GA57 
ΔCt Value (FLR) 8.33 9.44 8.82 
ΔCt Value (Control) 7.34 8.62 7.75 
ΔΔCt -0.99 -0.83 -1.07 
2^-ΔΔCt (Expression Fold Change) 1.98 1.77 2.10 
Table 2 Data from geriatric patients 2 years post-treatment with FLR 
 Using a separate one sample t-test to measure the effects of FLR treatment on IGF-1 
expression 1 and 2 years later, it can be seen in Figure 11 that the relative IGF-1 mRNA 
expression remained elevated in all subjects whose skin was examined in FLR treated areas 1 
year-post treatment. The same can be seen in for skin treated with FLR that was examined 2 
years-post treatment. The data in Figure 11 was expressed in terms of IGF-1 mRNA 
expression fold change with a null hypothesis that a mean fold change equal to 1 would 
indicate no difference after FLR treatment. Any significant p-value would indicate evidence 





The data from this experiment identifies skin rejuvenation techniques such as FLR as 
an adequate treatment for geriatric individuals and treatment with FLR additionally shows 
the added benefit of having a lasting impact on IGF-1 expression.  
 
Figure 11 
A bar graph illustrating the relative IGF-1 mRNA expression 1 and 2 years after treatment 





IGF-1 mRNA expression 1 year-post treatment with FLR is significantly different than 1. For 
this data set, the estimated mean difference in the data is 2.09, indicating a significant mean 
increase in IGF-1 mRNA expression 1 year after treatment with FLR. Based on a p value of 
0.0101, there is strong evidence to suggest the mean fold change in IGF-1 mRNA expression 
2 years after treatment with FLR is significantly different than 1. The estimated mean 
difference for this data set is 1.95, indicating a significant increase in IGF-1 mRNA 
expression 2 years after treatment with FLR. 
 
IGF-1R INHIBITION POTENTIATES PCNA MONO-UBIQUITINATION  
  Proliferating cell nuclear antigen (PCNA) has been shown to play an important role 
in DNA damage tolerance through its ubiquitination (Hoege et al., 2002). Upon exposure to 
genotoxic factors such as ultraviolet radiation, PCNA is either mono- or poly- ubiquitinated. 
PCNA mono-ubiquitination occurs at bulky DNA lesions that halt replication forks and this 
promotes the error-prone TLS DNA damage tolerance pathway (Kyoo-young Lee and 
Kyungjae Myung, 2008). In 2019, a colleague, Rebekah Hutcherson showed that UV-B 
radiation induced PCNA mono-ubiquitination in skin ex vivo. This mono-ubiquitination was 
more drastic in the skin of geriatric subjects (refer to Figure 8 above). For the final aim of 
this thesis, experiments were conducted using human skin ex vivo to investigate if deficient 
IGF-1 signaling is responsible for the increased PCNA mono-ubiquitination in geriatric skin.  
Human skin from abdominoplasty surgeries was used for these experiments. Skin was 
obtained from the indicated dates on Table 3 and divided into four sections per experiment. 
Two sections of skin were treated with a vehicle control (DMSO) and additional two sections 





incubation, one of two pieces from each group was subjected to various amounts of UV-B 
radiation (Table 3). The epidermis of each sample was harvested 1-2.5 hours after irradiation 
(Table 3). Epidermal cell lysates were prepared and then quantified by Bradford assay (Bio-
Rad Laboratories). Prepared epidermal cell lysates were separated using SDS-PAGE and 
then transferred on to a nitrocellulose membrane and signals in the linear range of detection 
for Ub-PCNA and total PCNA were quantified using Image Lab (Bio-Rad Laboratories).  






DMSO/AG535 700 J/m2 2.5 hours 
2/15/2017 39 
Female 
DMSO/AG535 700 J/m2 2 hours 
7/19/2017 39 
Female 
DMSO/AG535 1050 J/m2 2.5 hours 
9/20/2017 41 
Female 
DMSO/AG535 700 J/m2 2 hours 
7/12/17 44 
Female 
DMSO/AG538 700 J/m2 1 hour 
5/3/2017 48 
Female 
DMSO/AG535 700 J/m2 1 hour 
7/5/2017 48 
Female  
DMSO/AG535 700 J/m2 1 hour 
3/15/2017 49 
Female 
DMSO/AG535 1050 J/m2 1 hour 
4/19/2017 52 
Female 
DMSO/AG535 700 J/m2 1 hour 
5/31/2017 60 
Female 
DMSO/AG535 700 J/m2 1 hour 
Table 3 A table illustrating the date of abdominoplasty surgeries, treatments on skin with 
various amounts of UV-B radiation and time of epidermal harvest. 
 To analyze the data, all samples were normalized to DMSO + UV and the values for 





UV value. A one-sample t-test was performed to examine whether this ratio was different 
from 1.  
In Figures 12A and 13A below, the data and corresponding immunoblot for a 23-
year-old female can be seen. The subject’s discarded skin was treated as described above and 
sections were irradiated with 700 J/m2 of UV-B. The time of epidermal harvest was 2.5 hours 
after irradiation. When compared to the control value of 1 for DMSO treated skin in the 
presence of 700 J/m2 UV-B, the subject’s skin that was treated with AG538 in the presence 
of this same dose of UV-B showed a lesser amount of relative Ub-PCNA. This is consistent 
with the idea that a younger individual of 23 years should possess a relatively higher amount 
of IGF-1 whose keratinocytes are capable of appropriately carrying out a response to UV-B, 
thus less elevated PCNA mono-ubiquitination to indicate the recruitment of polymerases to 
repair any UVR induced DNA damage.  
 A drastic difference can be seen when comparing the data from the 23-year-old 
female to the data from a 60-year-old female (Figures 12J and 13I). The 60-year-old 
subject’s discarded skin was treated as described above and sections were also irradiated with 
700 J/m2 of UV-B. The time of epidermal harvest was 1 hour after irradiation. When 
compared to the control value of 1 for DMSO treated skin in the presence of UV-B, the 
subject’s skin that was treated with AG538 in the presence of the same dose of UV-B showed 
a much greater amount of relative Ub-PCNA. This is consistent with the idea that an older 
individual of 60 years should possess fewer amounts of IGF-1 whose keratinocytes are not 
capable of appropriately carrying out a response to UV-B. Without the appropriate response 
to UV-B induced DNA damage bulky photoproducts can form on DNA strands. PCNA 





and promote the error-prone TLS DNA damage tolerance pathway. This can explain the 
elevated levels of relative Ub-PCNA seen in this older subject. Thus, the data suggests that 
geriatric individuals who are deficient in IGF-1 are more dependent on the error-prone TLS 
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Bar graphs illustrating the data for skin samples obtained from the same patients, treated with 
AG538, AG538+ UV, DMSO and DMSO + UV. All samples were normalized to 
DMSO+UV, so the values for AG538+UV represent the ratio of its original value compared 
to the original DMSO+UV value. A one sample t-test was performed to determine whether 
this ratio was significantly different from 1.Based on a p-value of 0.03, there is strong 
evidence to suggest there is a significant difference in the mean PCNA ratio for AG538+UV 
compared to DMSO+UV. 

















































































































Protein immunoblotting data from skin harvested from different individuals treated with 







Summary of data from skin harvested from different individuals treated with DMSO, 





















IV:  DISCUSSION 
While non-melanoma skin cancers (NMSCs) can occur at any age, there exists a 
strong association between increasing age and skin cancer prevalence. With increasing age, 
there is a decline in DNA repair mechanisms. If DNA damage goes unrepaired this can lead 
to cellular senescence, which ultimately impedes damaged tissues from repairing themselves. 
In regards to our skin, this phenomenon can be seen within senescent fibroblasts in geriatric 
skin, which lack the ability to efficiently produce IGF-1. Our skin is reliant upon the 
production of IGF-1 to activate the IGF-1R on epidermal keratinocytes to carry out normal 
responses to repair damage inflicted by ultraviolet radiation. The decrease in IGF-1 
expression seen in geriatric skin is the central premise behind the experiment conducted for 
the first aim of this thesis, which sought to investigate more profoundly when IGF-1 begins 
to decrease with age. The results from this experiment showed that a gradual decrease in 
IGF-1 expression, secondarily, the data shows that a more substantial decline in IGF-1 occurs 
among people who are in their sixties.  
Although the results for this first experiment are consistent with what was 
hypothesized, I find it important to acknowledge the few limitations to the study. First, about 
93% of all the abdominoplasty skin collected for this first experiment was from females. The 
very few samples of skin that came from males were not used in this experiment because 
upon quantification, the values deviated substantially from other samples and were calculated 
as outliers. Secondly, since all of the skin used for this first experiment came abdominoplasty 
surgeries, it is important to note that a large amount of patients who elect to have this type of 
surgery are often overweight or obese, and may have poorer health than others. A third 





this study came from individuals who had abdominoplasty surgery in the years between 2016 
and 2019. Skin harvested more recently, and stored in RNA-later, may behave differently 
than the skin harvested from older years, such as from 2016.  
 The age-associated fibroblast senescence responsible for reduced IGF-1 expression 
has targeted IGF-1 restoration therapies as potential treatments for geriatric people. In studies 
where geriatric individuals were treated with fractionated laser resurfacing (FLR), a decrease 
in the percentage of senescent fibroblasts and an increase in dermal IGF-1 levels were 
observed 3 months after treatment (refer to Figures 5 and 6 above). The need for further 
confirmation was the basis behind the experiment conducted for the second aim of this thesis. 
The second aim attempted to confirm that the improvement of fibroblast IGF-1 levels 
reported 3 months after treatment with FLR are still present 1 and 2 years later. The results 
from this experiment showed that treatment with FLR in geriatric individuals does in fact 
have a lasting impact on IGF-1 expression both 1 and 2 years post-treatment.  
 The values for IGF-1 mRNA expression both 1 and 2 years after treatment with FLR 
remained higher than the values for geriatric skin not treated with FLR, as well as geriatric 
skin treated with FLR and allowed 3 months of healing. While the results from this second 
experiment are consistent with what was hypothesized, it is important to acknowledge the 
decline in the relative abundance of IGF-1 expression 2 years after treatment, compared to 1 
year-post treatment. This observance may indicate the need for repeated treatment with FLR 
2-3 years after initial treatment, but nonetheless does not dispute the fact that skin 
rejuvenation techniques such as FLR remain adequate treatment options for geriatric 





addition, since previous studies have identified FLR treatment equally as effective as 
dermabrasion, FLR treatment may be more optimal as it is less aggressive, and distressful to 
patients.  
 For the final aim of this thesis experiments were performed in order to determine 
whether IGF-1 deficiency itself is responsible for the increase of PCNA mono-ubiquitination 
seen in geriatric skin. The results from these experiments showed an increase in PCNA 
mono-ubiquitination in skin treated with an IGF-1R inhibitor, and an even more drastic 
increase in skin from people of advanced age. Given the results, it is very possible that IGF-1 
deficiency in geriatric skin is responsible for this increase and this suggests that geriatric skin 
may have an increased dependence on the error-prone TLS DNA damage tolerance pathway.  
In conclusion, the findings in this thesis validate the importance of IGF-1 in the skin 













6-4 PP- 6-4 Photoproducts 
BER- Base Excision Repair 
CPD- Cyclobutane Pyrimidine Dimers 
DBS- DNA Double Strand Break Repair 
DDT- Damage Tolerance Pathway 
FLR- Fractionated Laser Resurfacing 
GGR- Global Genome Repair 
IGF-1- Insulin-like Growth Factor 1 
IGF-1R- Insulin-like Growth Factor Receptor 
MMR- Mismatch Repair 
mRNA- Messenger RNA 
NER- Nucleotide Excision Repair 
NMSC- Non-Melanoma Skin Cancer 
PCNA- Poliferating Cell Nuclear Antigen 
PPR- Post-replication Repair 
ROS- Reactive Oxygen Species 





ssDNA- Single Stranded DNA 
TCR- Transcription Coupled Repair 
TLS- Translesion Synthesis 
TS- Template Switching 





















VI:  SUPPLEMENTAL MATERIALS 
Aim 1 data 
Obs Age Sex 
Copies_IGF1_1000_
B2M 
1 32 F 1.9107211556 
2 32 F 1.09 
3 32 F 3.19 
4 32 F 3.73 
5 36 F 0.3150310035 
6 36 F 1.2286846104 
7 37 F 5.8318327343 
8 37 F 3.7296037864 
9 39 F 2.74 
10 41 F 2.1735459943 
11 41 F 3.3877970532 
12 43 F 2.1141534147 
13 46 F 2.64 
14 46 F 2.0343520567 
15 46 F 3.5389599498 
16 46 F 1.1121274263 
17 46 F 1.616651332 
18 47 F 2.6 
19 48 F 2.24 
20 50 F 2.9233058741 
21 51 F 0.7741911886 
22 52 F 1.6602953271 





Obs Age Sex 
Copies_IGF1_1000_
B2M 
24 54 F 2.74 
25 56 F 0.8192484609 
26 59 F 2.6500589343 
27 60 F 0.87 
28 60 F 0.9867113173 
29 61 F 1.8892467511 
30 62 F 2.37 
31 62 F 1.6851152995 
32 63 F 2.1505970388 
33 65 F 1.6 
34 65 F 0.84 
35 67 F 2.09 
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Value Pr > F 












   
 
 
Root MSE 1.05880 R-Square 0.1149 
Dependent 
Mean 
2.13097 Adj R-Sq 0.0881 








Error t Value Pr > |t| 
Intercept Intercept 1 3.80632 0.82890 4.59 <.0001 






































































































































The REG Procedure 
Model: MODEL 1 































































Obs Subject Expression_Fold_Change 
1 4 3.7634669874 
2 6 2.4601033026 
3 10 1.7237505299 
4 13 3.6504438709 
DF t Value Pr > |t| 
3 3.87 0.0305 
N Mean Std Dev Std Err Minimum Maximum 
4 2.8
994 























































Obs Subject Expression_Fold_Change 
1 GA52 1.9845336246 
2 GA55 1.7718359271 
3 GA57 2.1012005148 
N Mean Std Dev Std Err Minimum Maximum 

















DF t Value Pr > |t| 






























































Q-Q Plot of Expression_Fold_Change
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Aim 3 Data 
Obs Subject Age Treatment PCNA ln_PCNA 
1 23 F (8-16-17) 23 DMSO -
UV 
0.04 -3.21888 
2 23 F (8-16-17) 23 DMSO 
+UV 
1 0.00000 
3 23 F (8-16-17) 23 AG538 -
UV 
0.36 -1.02165 
4 23 F (8-16-17) 23 AG538 
+UV 
0.41 -0.89160 
5 39 F (2-15-17) 39 DMSO -
UV 
0.21 -1.56065 
6 39 F (2-15-17) 39 DMSO 
+UV 
1 0.00000 
7 39 F (2-15-17) 39 AG538 -
UV 
0.29 -1.23787 
8 39 F (2-15-17) 39 AG538 
+UV 
1.38 0.32208 
9 39 F (7-19-17) 39 DMSO -
UV 
0.24 -1.42712 
10 39 F (7-19-17) 39 DMSO 
+UV 
1 0.00000 
11 39 F (7-19-17) 39 AG538 -
UV 
0.13 -2.04022 
12 39 F (7-19-17) 39 AG538 
+UV 
1.45 0.37156 
13 41 F (9-20-17) 41 DMSO -
UV 
0.12 -2.12026 
14 41 F (9-20-17) 41 DMSO 
+UV 
1 0.00000 
15 41 F (9-20-17) 41 AG538 -
UV 
0.47 -0.75502 





Obs Subject Age Treatment PCNA ln_PCNA 
17 44 F (7-12-17) 44 DMSO -
UV 
0.25 -1.38629 
18 44 F (7-12-17) 44 DMSO 
+UV 
1 0.00000 
19 44 F (7-12-17) 44 AG538 -
UV 
0.5 -0.69315 
20 44 F (7-12-17) 44 AG538 
+UV 
2.45 0.89609 
21 48 F (7-5-17) 48 DMSO -
UV 
0.21 -1.56065 
22 48 F (7-5-17) 48 DMSO 
+UV 
1 0.00000 
23 48 F (7-5-17) 48 AG538 -
UV 
0.28 -1.27297 
24 48 F (7-5-17) 48 AG538 
+UV 
2.67 0.98208 
25 48 F (5-3-17) 48 DMSO -
UV 
0.15 -1.89712 
26 48 F (5-3-17) 48 DMSO 
+UV 
1 0.00000 
27 48 F (5-3-17) 48 AG538 -
UV 
0.59 -0.52763 
28 48 F (5-3-17) 48 AG538 
+UV 
2.63 0.96698 
29 49 F (3-15-17) 49 DMSO -
UV 
0.47 -0.75502 
30 49 F (3-15-17) 49 DMSO 
+UV 
1 0.00000 
31 49 F (3-15-17) 49 AG538 -
UV 
0.55 -0.59784 
32 49 F (3-15-17) 49 AG538 
+UV 
1.05 0.04879 





Obs Subject Age Treatment PCNA ln_PCNA 
34 52 F (4-19-17) 52 DMSO 
+UV 
1 0.00000 
35 52 F (4-19-17) 52 AG538 -
UV 
0.41 -0.89160 
36 52 F (4-19-17) 52 AG538 
+UV 
2.39 0.87129 
37 60 F (5-31-17) 60 DMSO -
UV 
0.17 -1.77196 
38 60 F (5-31-17) 60 DMSO 
+UV 
1 0.00000 
39 60 F (5-31-17) 60 AG538 -
UV 
0.14 -1.96611 









Columns in X 10 
Columns in Z 0 
Subjects 10 
Max Obs per Subject 4 
Number of Observations 
Number of Observations Read 40 
Number of Observations Used 40 
Number of Observations Not 
Used 
0 




Subject 10 23 F (8-16-17) 39 F (2-15-17) 39 F (7-19-17) 41 F (9-20-17) 44 F (7-12-17) 48 F (5-3-17) 48 F (7-
5-17) 49 F (3-15-17) 52 F (4-19-17) 60 F (5-31-17) 
Treatme
nt 






Dependent Variable PCNA 
Covariance Structure Variance 
Components 
Subject Effect Subject 




Fixed Effects SE Method Kenward-Roger 

















Covariance Parameter Estimates 
Cov Parm Subject Estimate 




-2 Res Log Likelihood 67.0 
AIC (Smaller is Better) 69.0 
AICC (Smaller is Better) 69.1 









2 Res Log Lik
e Criterion 
0 1 66.98159819  












0 0.00 1.0000 
 
 







Value Pr > F 
Treatment 3 32 0.76 0.5260 
Age 1 32 3.12 0.0871 
Age*Treatment 3 32 2.10 0.1197 
 
 
Least Squares Means 
Effect Treatment Estimate 
Standard 
Error DF t Value Pr > |t| 
Treatment AG538 
+UV 
1.6590 0.1236 32 13.43 <.0001 
Treatment AG538 -
UV 
0.3720 0.1236 32 3.01 0.0051 
Treatment DMSO 
+UV 
1.0000 0.1236 32 8.09 <.0001 
Treatment DMSO -
UV 











































































































































































AG538 +UV AG538 -UV DMSO +UV DMSO -UV
Treatment































Dependent Variable ln_PCNA 
Covariance Structure Variance 
Components 
Subject Effect Subject 




Fixed Effects SE Method Kenward-Roger 









Subject 10 23 F (8-16-17) 39 F (2-15-17) 39 F (7-19-17) 41 F (9-20-17) 44 F (7-12-17) 48 F (5-3-17) 48 F (7-
5-17) 49 F (3-15-17) 52 F (4-19-17) 60 F (5-31-17) 
Treatme
nt 







Columns in X 10 
Columns in Z 0 
Subjects 10 





Number of Observations 
Number of Observations Read 40 
Number of Observations Used 40 











2 Res Log Lik
e Criterion 
0 1 78.87092333  








Covariance Parameter Estimates 
Cov Parm Subject Estimate 






-2 Res Log Likelihood 78.9 
AIC (Smaller is Better) 80.9 
AICC (Smaller is Better) 81.0 
BIC (Smaller is Better) 81.2 
 
 




Square Pr > ChiSq 
0 0.00 1.0000 
 
 
Type 3 Tests of Fixed Effects 





Value Pr > F 
Treatment 3 32 5.10 0.0053 
Age 1 32 6.28 0.0175 
Age*Treatment 3 32 2.89 0.0507 
 
 
Least Squares Means 
Effect Treatment Estimate 
Standard 
Error DF t Value Pr > |t| 
Treatment AG538 +UV 0.3699 0.1488 32 2.49 0.0183 
Treatment AG538 -UV -1.1004 0.1488 32 -7.40 <.0001 
Treatment DMSO +UV 8.88E-16 0.1488 32 0.00 1.0000 













































































































































































AG538 +UV AG538 -UV DMSO +UV DMSO -UV
Treatment






























Dependent Variable ln_PCNA 
Covariance Structure Variance 
Components 
Subject Effect Subject 




Fixed Effects SE Method Kenward-Roger 









Subject 10 23 F (8-16-17) 39 F (2-15-17) 39 F (7-19-17) 41 F (9-20-17) 44 F (7-12-17) 48 F (5-3-17) 48 F (7-
5-17) 49 F (3-15-17) 52 F (4-19-17) 60 F (5-31-17) 
Treatme
nt 







Columns in X 6 





Max Obs per Subject 4 
 
 
Number of Observations 
Number of Observations Read 40 
Number of Observations Used 40 




Iteration Evaluations -2 Res Log Like Criterion 
0 1 69.17103444  







Covariance Parameter Estimates 
Cov Parm Subject Estimate 






-2 Res Log Likelihood 69.2 
AIC (Smaller is Better) 71.2 
AICC (Smaller is Better) 71.3 
BIC (Smaller is Better) 71.5 
 
 
Null Model Likelihood Ratio Test 
DF Chi-Square Pr > ChiSq 
0 0.00 1.0000 
 
 
Solution for Fixed Effects 
Effect Treatment Estimate 
Standard 
Error DF t Value Pr > |t| 
Intercept  -2.5213 0.4120 35 -6.12 <.0001 
Treatment AG538 +UV 2.0090 0.2268 35 8.86 <.0001 
Treatment AG538 -UV 0.5387 0.2268 35 2.38 0.0231 
Treatment DMSO +UV 1.6391 0.2268 35 7.23 <.0001 
Treatment DMSO -UV 0 . . . . 
Age  0.01991 0.008567 35 2.32 0.0260 
 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Treatment 3 35 34.09 <.0001 





Least Squares Means 
Effect Treatment Estimate 
Standard 
Error DF t Value Pr > |t| Alpha Lower Upper 
Treatment AG538 +UV 0.3699 0.1604 35 2.31 0.0271 0.05 0.04432 0.6955 
Treatment AG538 -UV -1.1004 0.1604 35 -6.86 <.0001 0.05 -1.4260 -0.7748 
Treatment DMSO +UV -444E-18 0.1604 35 -0.00 1.0000 0.05 -0.3256 0.3256 
Treatment DMSO -UV -1.6391 0.1604 35 -10.22 <.0001 0.05 -1.9647 -1.3135 
 
 












































































































Differences of Least Squares Means 









































































































































































































AG538 +UV AG538 -UV DMSO +UV DMSO -UV
Treatment
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Treatment AG538 +UV AG538 -UV DMSO +UV DMSO -UV
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